Document is current
Any future updates will be listed below
-
Authors
Brown, Rachel L. https://orcid.org/0000-0002-9932-0228
Thomas-Black, Gilbert
Garcia-Moreno, Hector
Chou, Michael
Fleszar, Zofia
Zandi, Michael S.
Chapman, Miles
Church, Andrew J.
Hart, Melanie
Giunti, Paola
Vincent, Angela
Lunn, Michael P.
-
Funding
Funding for this research was provided by:
Medical Research Council (MR/T001313/1)
University College London Hospitals Biomedical Research Centre
National Brain Appeal
CureSCA3
- License Information
-
More Information
Article History
Received: 16 September 2024
Revised: 11 November 2024
Accepted: 26 November 2024
First Online: 22 February 2025
Declarations
:
: MZ has received fees for lectures for the Norwegian Neurological Society; Copenhagen Neuropsychological Society, Rigshospitalet; Cygnet Healthcare; GSK; and UCB Pharma, and personal fees to attend the European Association of Neurology (EAN) meeting on autoimmune encephalitis in April 2022. MH has received consulting fees from Accenture Consulting. PG has received grants and honoraria for advisory board from Vico Therapeutics, honoraria for advisory board from Triplet Therapeutics, grants and personal fees from Reata Pharmaceutical, grants from Wave. AV and the University of Oxford receive royalties for LGI1 and CASPR2 antibodies. AV has received lecture fees from Alexion, UCB and Johnson&Johnson.
